Want to join the conversation?
$CTL 2Q15 PR: Excluding special items and CAF Phase 2, CTL expects 3Q15 operating revenues of $4.42-4.47Bil, core revenues of $4.02-4.07Bil, adjusted diluted EPS of $0.53-0.58 and expects 2015 operating revenues of $17.7-17.9Bil, core revenues of $16.10-16.25Bil & adjusted diluted EPS of $2.35-2.55.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?